Novel Functions of the E-C Coupling Structural Protein Junctophilin-2 in the Heart
E-C 偶联结构蛋白 Junctophilin-2 在心脏中的新功能
基本信息
- 批准号:10478204
- 负责人:
- 金额:$ 60.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-01-15 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelAttenuatedBiochemicalCalpainCardiacCardiac MyocytesCardiovascular DiseasesCell Culture TechniquesCell NucleusCell membraneCell modelComplexCouplingDataDevelopmentDiseaseDown-RegulationFunctional disorderFundingFutureGenerationsGeneticGenetic TranscriptionGoalsHeartHeart DiseasesHeart failureHomeostasisHumanKnock-in MouseLinkMediatingMediator of activation proteinMembraneModificationMolecularMusMuscle CellsMutateMutationMutation AnalysisMyocardial InfarctionN-terminalNuclearNuclear ImportNuclear TranslocationOutcomePathogenesisPathologicPathway interactionsPatientsPhosphorylationPhosphotransferasesPhysiologicalPhysiologyPost-Translational Protein ProcessingPrevalenceProcessProductionProteinsProteolysisRegulationResearchResistanceRoleSarcoplasmic ReticulumSignal PathwaySignal TransductionSiteStressStructural ProteinStructureTestingTherapeuticTranscriptTranscriptional RegulationTranslationsTreatment FailureTubular formationVentricularbasebiological adaptation to stresscardioprotectioncardiovascular healthdesignexperimental studyheart functionheart preservationimprovedin vitro Assayin vivoinsightjunctophilinmimeticsmultidisciplinarymutantnoveloverexpressionpreservationpressurepreventresponsetooltranscriptional reprogramming
项目摘要
PROJECT SUMMARY
Junctophilin 2 (JP2) is an essential structural protein required for the formation of junctional couplings (i.e.,
cardiac dyads) between the transverse (T)-tubule membrane and the sarcoplasmic reticulum (SR). JP2 function
is therefore fundamental for the local control of Ca2+-induced Ca2+ release and efficient contraction in ventricular
myocytes during cardiac excitation-contraction (E-C) coupling. JP2 protein levels progressively decline in failing
human hearts and in animal models of heart failure leading to T-tubule remodeling and loss of E-C coupling
function. The downregulation of JP2 at E-C coupling sites is in part due to specific cleavage by the Ca2+-activated
protease calpain that is implicated in a variety of heart diseases. During the previous funding period, we
demonstrated that stress- and calpain-dependent cleavage of JP2 liberates a novel, nuclear translocating, N-
terminal fragment (JP2NT) that represses maladaptive transcriptional reprogramming in diseased hearts, thus
transducing E-C uncoupling information into a unique cardio-protective excitation-transcription (E-T) coupling
signal to the nucleus. However, how JP2-mediated E-C and E-T coupling phenomena are mechanistically regulated
remains to be determined. Our new preliminary results show that JP2 is reproducibly phosphorylated in stressed
hearts near regions responsible for JP2 cleavage and the subcellular localization of JP2NT. In this competitive
renewal application, we aim to define how stress-induced post-translational modifications regulate the structure,
localization, and function of JP2/JP2NT. We hypothesize that JP2NT-mediated E-T coupling is tightly regulated
by cardiac stress-dependent phosphorylation of JP2 that determines JP2 sensitivity to calpain and JP2NT
nuclear translocation and transcriptional activity. To test our hypothesis, in Aim 1, we will use mutation analysis
and cell models to determine how JP2 phosphorylation regulates E-C coupling and cleavage-induced JP2NT
generation, nuclear translocation and transcriptional regulation. In Aim 2, we will utilize our novel JP2 calpain
resistant mice in combination with JP2NT overexpression to determine how these targeted approaches modulate
cardiac responses to stress in vivo. We will determine how E-C coupling structure/function and cardiac gene
transcription are altered in these mice in response to pressure overload and myocardial infarction. We expect
our studies will provide significant insights into the regulatory mechanisms governing JP2/JP2NT function and
their salutary contribution toward heart disease pathogenesis.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Long-Sheng Song其他文献
Long-Sheng Song的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Long-Sheng Song', 18)}}的其他基金
ERK1/2-Integrin Signaling in Desmosome-Dyad Crosstalk
桥粒-二元串扰中的 ERK1/2-整合素信号转导
- 批准号:
10198251 - 财政年份:2021
- 资助金额:
$ 60.53万 - 项目类别:
Molecular Determinants of MG53 in Heart Structure and Function
MG53 在心脏结构和功能中的分子决定因素
- 批准号:
10685305 - 财政年份:2021
- 资助金额:
$ 60.53万 - 项目类别:
Molecular Determinants of MG53 in Heart Structure and Function
MG53 在心脏结构和功能中的分子决定因素
- 批准号:
10199214 - 财政年份:2021
- 资助金额:
$ 60.53万 - 项目类别:
ERK1/2-Integrin Signaling in Desmosome-Dyad Crosstalk
桥粒-二元串扰中的 ERK1/2-整合素信号转导
- 批准号:
10687055 - 财政年份:2021
- 资助金额:
$ 60.53万 - 项目类别:
Oxidative Stress, PKC Signaling and Heart Failure
氧化应激、PKC 信号传导和心力衰竭
- 批准号:
9029006 - 财政年份:2016
- 资助金额:
$ 60.53万 - 项目类别:
Understanding the multifaceted functions of MG53 in heart failure pathogenesis
了解 MG53 在心力衰竭发病机制中的多方面功能
- 批准号:
9889409 - 财政年份:2016
- 资助金额:
$ 60.53万 - 项目类别:
Novel Functions of the E-C Coupling Structural Protein Junctophilin-2 in the Heart
E-C 偶联结构蛋白 Junctophilin-2 在心脏中的新功能
- 批准号:
10058735 - 财政年份:2016
- 资助金额:
$ 60.53万 - 项目类别:
Novel Functions of the E-C Coupling Structural Protein Junctophilin-2 in the Heart
E-C 偶联结构蛋白 Junctophilin-2 在心脏中的新功能
- 批准号:
10689197 - 财政年份:2016
- 资助金额:
$ 60.53万 - 项目类别:
Novel functions of E-C coupling structural protein junctophilin-2 in the heart
E-C耦合结构蛋白junctophilin-2在心脏中的新功能
- 批准号:
9199431 - 财政年份:2016
- 资助金额:
$ 60.53万 - 项目类别:
T-tubule remodeling and Ca2+-dependent arrhythmogenesis in cardiomyopathies.
心肌病中的 T 管重塑和 Ca2 依赖性心律失常发生。
- 批准号:
7837390 - 财政年份:2009
- 资助金额:
$ 60.53万 - 项目类别:
相似海外基金
A platform for rapidly generating live attenuated enterovirus vaccines
快速生成减毒肠道病毒活疫苗的平台
- 批准号:
24K02286 - 财政年份:2024
- 资助金额:
$ 60.53万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
I-Corps: Translation potential of an efficient method to generate live-attenuated and replication-defective DNA viruses for vaccine development
I-Corps:一种有效方法的转化潜力,可生成用于疫苗开发的减毒活病毒和复制缺陷型 DNA 病毒
- 批准号:
2420924 - 财政年份:2024
- 资助金额:
$ 60.53万 - 项目类别:
Standard Grant
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
- 批准号:
10596047 - 财政年份:2023
- 资助金额:
$ 60.53万 - 项目类别:
Live attenuated non-transmissible (LANT) Klebsiella pneumoniae vaccines
肺炎克雷伯氏菌减毒非传染性 (LANT) 活疫苗
- 批准号:
10742028 - 财政年份:2023
- 资助金额:
$ 60.53万 - 项目类别:
Protecting Pigs From Enzootic Pneumonia: Rational Design Of Safe Attenuated Vaccines.
保护猪免受地方性肺炎:安全减毒疫苗的合理设计。
- 批准号:
BB/X017540/1 - 财政年份:2023
- 资助金额:
$ 60.53万 - 项目类别:
Research Grant
A “Goldilocks” live attenuated poultry vaccine for Infectious Coryza
用于传染性鼻炎的“Goldilocks”家禽减毒活疫苗
- 批准号:
LP210301365 - 财政年份:2023
- 资助金额:
$ 60.53万 - 项目类别:
Linkage Projects
A novel live-attenuated Zika vaccine with a modified 5'UTR
一种带有改良 5UTR 的新型寨卡减毒活疫苗
- 批准号:
10730832 - 财政年份:2023
- 资助金额:
$ 60.53万 - 项目类别:
Combating melanoma with an attenuated bacterial therapeutic
用减毒细菌疗法对抗黑色素瘤
- 批准号:
10659841 - 财政年份:2023
- 资助金额:
$ 60.53万 - 项目类别:
Investigating Host and Viral Factors for Improved Design of Future Live Attenuated Vaccines for IBV
研究宿主和病毒因素以改进未来 IBV 减毒活疫苗的设计
- 批准号:
BB/V016067/1 - 财政年份:2022
- 资助金额:
$ 60.53万 - 项目类别:
Research Grant
L2M NSERC-Bioengineering attenuated Sclerotinia sclerotiorum strains as bioherbicide for cereal production and lawn management
L2M NSERC-生物工程减毒核盘菌菌株作为谷物生产和草坪管理的生物除草剂
- 批准号:
576545-2022 - 财政年份:2022
- 资助金额:
$ 60.53万 - 项目类别:
Idea to Innovation














{{item.name}}会员




